Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infection

The Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infection (APRHAI) provides practical and scientific advice to the government on minimising the risk of healthcare associated infections.


Current members are:

  • Professor Alistair Leanord (Chair)
  • Dr Nick Brown
  • Professor Philip Howard
  • Dr Peter Moss
  • Dr Laura Shallcross
  • Professor Martin Llewelyn
  • Dr Sarah Tonkin-Crine
  • Mr Neil Wigglesworth
  • Dr Jonathan Sandoe
  • Ms Eleanor Kashouris (Lay Member)
  • Ms Ashely Flores
  • Professor Benjamin Cooper
  • Ms Vanessa Carter (Lay Member)
  • Dr Benjamin Parcell

Code of practice

Members' code of practice (PDF, 485 KB, 17 pages)

Members’ interests

Register of Members' Interests (PDF, 179 KB, 3 pages)

Meeting dates

  • 31 March 2023
  • 30 June 2023
  • 27 September 2023


Read minutes and papers of APRHAI meetings.

Read minutes of meetings before September 2012.


Read APRHAI publications and annual reports.

Terms of reference

The purpose of APRHAI is to provide practical and scientific advice to government in support of the fulfilment of its vision for antimicrobial resistance (AMR) in 2040 and on strategies to:

  • reduce the incidence of healthcare associated infections (HAI) and specific drug-resistant infections
  • effectively control, contain and mitigate AMR
  • optimise antimicrobial use (AMP) in humans

In doing this, the committee will:

  • take into account the relevant work of other expert groups in the human and veterinary fields when making its recommendations
  • help guide government’s scientific priorities and work, including horizon-scanning and long-range planning as well as dealing with immediate risks and opportunities
  • keep aware of international scientific developments that might impact the UK’s approach
  • identify gaps in the evidence base that require further research or surveillance and make recommendations for prioritisation
  • make its findings and recommendations available to government, and the public, in a way which aims to be comprehensive, understandable and timely
  • review and evaluate the effectiveness of the on-going work of the committee
  • operate in line with the government’s principles for scientific advice and the code of practice for scientific advisory committees, including making the work of the committee open, transparent and accessible as well as strengthening public and patient engagement

Contact details